Project Grant R35GM157134

Award Date 5/1/25
Completion Date 3/31/30
Dollars Obligated $424K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), will support the development of advanced statistical approaches for performing large-scale composite hypothesis testing in translational genetics research. The $408,750 award, granted to the University of Texas MD Anderson Cancer Center, aims to create novel, interpretable, and robust methods for conducting pleiotropy,...
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides funding of $122,234 to The Trustees of Columbia University in the City of New York, Health Sciences Division, to conduct research aimed at enhancing disease association mapping and risk prediction accuracy through a Liability Threshold-based Phenotypic Integration (LTPI) model. The key objectives are to: 1) Develop a multi-trait model to maximize statistical power and...
The National Institute of General Medical Sciences (NIGMS) is providing a 5-year, $370,976 project grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Kansas Center for Research Inc. to identify genetic variants affecting gene regulation that underlie complex trait variation and fitness in natural populations. The research aims to integrate studies of tissue-specific gene regulation, population genomic surveys, and new sequencing/computational...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $325,838 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Florida to develop new computational methods for modeling complex genetic interactions and predicting phenotypes from genotypes. The primary goals are to (1) create scalable Bayesian and machine learning approaches capable of modeling higher-order epistasis, and (2) build an integrated software framework to enable...
This $695,534 Project Grant award was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The grant supports research aimed at generating a more comprehensive understanding of the mechanisms of drug response and their sources of variation in order to enable more precise drug therapies. Key focus areas include: (1) characterizing the full range of clinical responses to drugs, (2) identifying molecular...
This federal Project Grant award, provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), aims to develop new methods to predict disease risk among individuals with rare monogenic disease risk alleles. The $1,100,866 award to the Icahn School of Medicine at Mount Sinai will leverage deep learning techniques to integrate genetic, electronic health record, metabolomics, and proteomics data to produce accurate risk predictions and gain...
The Project Grant award R35GM149520 in the amount of $775,170 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to decode the regulatory mechanisms within the human genome. The project aims to better understand how transcription factors and other regulatory DNA features cooperatively control gene expression patterns during development and in response to various stimuli. Using advanced...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $359,490 to the University of Florida to develop a suite of deep learning methods for integrating single-cell genomic data into genetic analysis. The primary goals are to: 1) create a deep learning model to predict gene expression from DNA sequences, 2) design a unified deep learning framework to connect single-cell reference...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $243,840 to the University of Pittsburgh to develop innovative approaches for understanding and restoring the normal function of proteins affected by mutations. The key objectives are to reliably distinguish between neutral and deleterious protein mutations and learn how to repair these problems by introducing compensating...
This $409,896 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of new statistical methods and analyses to leverage functional genomics data, in conjunction with genome-wide association study (GWAS) data, to better understand the functional effects of genetic variants and their roles in human diseases. The key objectives of this 5-year research program are to: (i) identify...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA program 93.859 Biomedical Research and Research Training, provides $423,750.00 to New York University (NYU) School of Medicine to conduct research aimed at deconstructing the genetic basis of complex trait variation.

The key objectives of the project are: 1) to understand which genes contribute most to complex traits, leveraging data from genome-wide association studies (GWAS) and rare coding variants; 2) to characterize gene-gene and gene-environment interactions that influence complex traits; and 3) to develop approaches to improve the accuracy and interpretability of polygenic scores for disease prediction. The project will utilize large biomedical datasets from initiatives like the UK Biobank and All of Us to implement and test the researchers' new conceptual and statistical models. The award has a project period from May 1, 2025 to March 31, 2030.

Generated 5/13/25, 4:33 AM